Actively Recruiting
Comparison of Single-port and Multi-port Robotic Surgery for Rectal Cancer Evaluating Safety and Short-Term Clinical Outcomes
Led by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Updated on 2026-08-04
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating robotic surgical methods for treating rectal cancer in this clinical trial. The study compares single-port robotic total mesorectal excision with multi-port robotic total mesorectal excision to assess safety and short-term clinical outcomes in adult patients. This stage 2 trial follows the IDEAL framework and aims to provide insights into intraoperative and postoperative effects of these surgical techniques. The study includes two phases Phase I is a single-arm study involving 20 patients undergoing single-port robotic surgery, and Phase II is a non-randomized controlled study comparing 100 patients receiving single-port surgery versus 100 patients receiving multi-port surgery. Both surgical procedures involve robotic total mesorectal excision, and the study monitors various perioperative and postoperative factors. Participants will be assessed for complications during and up to 30 days after surgery, conversion rates to other procedures, operation time, blood loss, and recovery indicators such as time to first flatus and hospital stay duration. Secondary assessments include incision length, pain scores on the first three days after surgery, quality of the surgical specimen, and lymph node analysis. The study involves close monitoring during the hospital stay and recovery period to gather these outcome measures.
CONDITIONS
Brief Title
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Research Team
H
Huichao Zheng, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here